NHAS

Novo Holdings A/S Portfolio holdings

AUM $1.42B
1-Year Return 12.08%
This Quarter Return
+21.58%
1 Year Return
+12.08%
3 Year Return
+99.82%
5 Year Return
+98.46%
10 Year Return
+612.59%
AUM
$2.01B
AUM Growth
+$159M
Cap. Flow
-$121M
Cap. Flow %
-6.02%
Top 10 Hldgs %
68.56%
Holding
39
New
1
Increased
7
Reduced
7
Closed
2

Top Buys

1
ZBIO
Zenas BioPharma, Inc. Common Stock
ZBIO
$19.5M
2
VRDN icon
Viridian Therapeutics
VRDN
$8.76M
3
CLDX icon
Celldex Therapeutics
CLDX
$3.86M
4
MRUS icon
Merus
MRUS
$1.25M
5
FDMT icon
4D Molecular Therapeutics
FDMT
$1.08M

Top Sells

1
AAPL icon
Apple
AAPL
$38.5M
2
CRM icon
Salesforce
CRM
$30.5M
3
PCVX icon
Vaxcyte
PCVX
$22.9M
4
EWTX icon
Edgewise Therapeutics
EWTX
$21.2M
5
BN icon
Brookfield
BN
$20.7M

Sector Composition

1 Healthcare 57.87%
2 Financials 10.69%
3 Technology 10.64%
4 Consumer Discretionary 2.64%
5 Communication Services 2.06%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ZBIO
26
Zenas BioPharma, Inc. Common Stock
ZBIO
$864M
$19.5M 0.97%
+1,150,000
New +$19.5M
FDMT icon
27
4D Molecular Therapeutics
FDMT
$340M
$16.2M 0.81%
1,500,000
+100,000
+7% +$1.08M
BPMC
28
DELISTED
Blueprint Medicines
BPMC
$16.2M 0.8%
175,000
– –
VERV
29
DELISTED
Verve Therapeutics
VERV
$11.6M 0.58%
2,400,000
– –
LXEO icon
30
Lexeo Therapeutics
LXEO
$271M
$10.1M 0.5%
1,122,581
-327,919
-23% -$2.96M
KYTX icon
31
Kyverna Therapeutics
KYTX
$170M
$9.05M 0.45%
1,850,000
+100,000
+6% +$489K
MGX icon
32
Metagenomi
MGX
$71.7M
$3.91M 0.19%
1,800,000
– –
IOBT icon
33
IO Biotech
IOBT
$128M
$3.52M 0.17%
3,354,449
-1,075,000
-24% -$1.13M
ABCL icon
34
AbCellera Biologics
ABCL
$1.26B
$2.93M 0.15%
1,126,915
– –
MQ icon
35
Marqeta
MQ
$2.76B
$2.17M 0.11%
441,558
– –
GLTO icon
36
Galecto
GLTO
$3.99M
$1.21M 0.06%
99,913
+1
+0% +$12
SPRO icon
37
Spero Therapeutics
SPRO
$121M
$628K 0.03%
468,902
– –
AAPL icon
38
Apple
AAPL
$3.56T
– –
-182,960
Closed -$38.5M
MORF
39
DELISTED
Morphic Holding, Inc. Common Stock
MORF
– –
-375,000
Closed -$12.8M
1
2